Tirzepatide is a dual GLP-1 and GIP receptor agonistmeaning it activates two separate appetite-regulating pathwaysand demonstrates 2022% weight loss in clinical trials over 72 weeks
Yaming Liu, Department of Gastroenterology and Hepatology, Xiamen University Zhongshan Hospital, Xiamen, Fujian Province, China
What should one consider when incorporating peptide therapy into a wellness or longevity plan
Eur J Pharmacol 910:174506
So, lets try bringing a bit of clarity to your choices and help you feel better informed and empowered before your next visit to the doctor
The process of losing weight on semaglutide requires more than just taking your weekly injection or daily pill, explains Suzanna Thoe, RD, a registered dietitian specializing in weight management